SIAXI, NCT02091739 / 2012-005539-10: Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions |
|
|
| Completed | 3 | 184 | Europe | IncobotulinumtoxinA (100 Units), Xeomin, NT 201, Botulinum toxin type A (150 kiloDalton), free from complexing proteins, IncobotulinumtoxinA (75 Units), Placebo | Merz Pharmaceuticals GmbH | Chronic Troublesome Sialorrhea, Parkinson's Disease, Post-stroke, Traumatic Brain Injury | 08/15 | 11/16 | | |
